Fat freezing can cause temporary bruising, swelling and discomfort. It can also cause complications that need medical care, including cold burns and delayed enlargement of the treated fat. These are different problems, with different patterns and consequences. The FDA’s cryolipolysis guidance describes both short-lived effects and potentially lasting harm.
Before booking, understand what changes to expect, which symptoms need assessment and how to obtain help. If you have already been treated and something concerns you, use that contact route now; this guide cannot diagnose the area.

Temporary effects still deserve a clear explanation
Cryolipolysis uses controlled cooling to target local fat beneath the skin. During treatment, pulling, cold, stinging or cramping can occur. Afterwards, redness, bruising, tenderness, swelling and altered sensation are recognised effects. CoolSculpting’s UK patient information describes these as generally resolving over days or weeks, with numbness sometimes lasting several weeks. These descriptions concern that branded system, not every machine sold as fat freezing. Manufacturer UK Q&A.
Ask what the practitioner expects for your proposed body area and device. “Temporary” does not tell you how much a symptom might affect sleep, clothing or work. Explain any activities you cannot easily rearrange, rather than assuming an elective treatment will have no effect on your plans.
Most people resume everyday activities soon after non-invasive fat removal, but the American Academy of Dermatology also recognises rare lasting pain after fat freezing. A recovery estimate is therefore a planning aid, not a promise. AAD patient guide.
Symptoms that should not wait for a results review
Severe or worsening pain, blistering or marked skin colour changes need prompt medical assessment. A list of expected side effects cannot establish that a particular symptom is harmless. Freeze burns can damage deeper skin layers; they are among the complications identified by the FDA.
If the skin develops blisters after cold exposure, looks white or blue and feels hard, or you suspect a cold burn, seek urgent medical help. NHS frostbite guidance advises A&E assessment for serious signs such as hard frozen skin or fluid-filled blisters. Do not rub a suspected cold injury or apply direct heat. NHS cold-injury guidance.
Tell the treating provider, but do not let difficulty reaching them delay medical care. In Wales, call 111 if you need urgent advice about where to obtain assessment. NHS 111 Wales provides this route for burn concerns. Give the treatment date, body area and device name if you know it. Describe what changed and when, without trying to label it yourself.
PAH is a delayed change in the treated fat
Paradoxical adipose hyperplasia, usually shortened to PAH, means that treated fatty tissue enlarges instead of becoming smaller. It can produce a firm, raised bulge, sometimes resembling the applicator’s outline. The FDA describes reported onset two to five months after treatment. PAH does not normally disappear by itself and may require surgery, whose outcome is not guaranteed. FDA explanation of PAH.
A growing firm bulge deserves assessment even if it is not painful. Contact the provider and arrange a medical review rather than assuming it is weight gain or booking another treatment to reduce it. This description is a reason to seek help, not a way to diagnose a lump at home.
Keep your treatment details and describe the progression at the appointment. You can ask whether photographs from before treatment would help the assessment. If a complication is suspected, ask who will establish the diagnosis and explain the options. You should not have to decide from an online photograph whether you need surgery.
What does the 2025 PAH estimate actually mean?
A 2025 systematic review and meta-analysis by Mah and colleagues combined 28 studies involving 13,078 patients. It estimated PAH incidence at 0.22%, with a 95% confidence interval of 0.10–0.47%, and rated the evidence low certainty.
Here, incidence means the proportion of treated patients who developed PAH during the studies’ follow-up. The confidence interval expresses statistical uncertainty around the pooled estimate; it does not account fully for missed cases or incomplete follow-up. Only four studies reported follow-up of at least 16 weeks. A delayed complication can be missed when observation ends early.
This is a patient-based estimate, not a risk per treatment cycle, and it is not a measured rate for our Cardiff clinic. Patients may receive multiple applicator cycles. The review could not establish reliable device-specific rates or a definitive difference by sex. A newer applicator should therefore not be described as eliminating PAH.
Questions to settle before giving consent
Bring these questions to a consultation and ask for answers you can take away:
- Which device and applicator would you use? Request its patient information and the risks relevant to your treatment area.
- Who will assess and perform the treatment? Ask about their training for that device and their experience recognising complications.
- How are my concerns documented? Explain your medical history and ask how the assessment changes the proposed plan.
- Who can I contact afterwards? Establish a route for concerning symptoms between appointments, including outside opening hours.
- How are delayed changes reviewed? Ask how a suspected PAH case would be assessed and referred, and who would discuss further treatment and costs.
- What if I choose to wait or decline? Allow yourself time to weigh a possible contour change against the risks and uncertainty.

These are suggested questions, not a description of this clinic’s arrangements. Read the answers alongside the actual device information. The CoolSculpting consumer safety leaflet, for example, asks patients to report any worrying symptom. Its instructions apply to that system; mentioning it here does not mean our clinic uses it.
For the separate question of medical eligibility, see am I suitable for fat freezing?. You can bring your safety questions to an enquiry about the Cardiff clinic at 28 Cathedral Road. A consultation should leave you able to explain the risks and follow-up arrangements in your own words before deciding.
Sources and further reading
- FDA: Non-Invasive Body Contouring Technologies.
- Mah et al. (2025): Incidence of Paradoxical Adipose Hyperplasia After Cryolipolysis: A Systematic Review and Meta-Analysis.
- CoolSculpting: full consumer safety information, internal revision October 2025.
- CoolSculpting UK: Q&A and safety information.
- American Academy of Dermatology: Non-invasive fat removal — what can you expect?.
- NHS: Frostbite and NHS 111 Wales: Burns and scalds.
Frequently Asked Questions
Does swelling straight after fat freezing mean PAH?
Immediate swelling is a recognised temporary effect. PAH is a different, delayed enlargement of treated fat. Timing alone cannot identify a complication; ask for assessment if swelling worsens, concerns you or develops into a growing firm bulge.
Is 0.22% my personal chance of developing PAH?
No. It is a pooled patient estimate from a 2025 review with low-certainty evidence. It is neither a per-cycle figure nor a measured risk for the Cardiff clinic or your proposed treatment.
Should I wait for my results appointment if the skin blisters?
No. Blistering after cold exposure needs urgent medical assessment. Severe or worsening pain and marked skin colour changes also need prompt attention; do not wait for a routine cosmetic review.
What should I ask about follow-up before agreeing to treatment?
Ask who assesses concerns, how to contact them between appointments, what happens if a complication is suspected and how referrals and any further treatment costs are handled. Request the actual device's patient information.

